AD
Ascent Consumer Products recalled one lot of SinuCleanse Soft Tip Squeeze Bottle Nasal Wash System. The affected lot was only sold in January 2025, the company said. The recalled lot number is 024122661A1, and the expiration date is 12-31-2027.
Nasal washes and rinses are meant to temporarily ease symptoms of cold and flu, sinusitis, and allergies.
The FDA said using the contaminated product could lead to serious, potentially life-threatening blood infections, especially when the sinuses are already inflamed from illness or injured from using a nasal wash.
A bloodstream staph infection can lead to secondary infections including:
Eye infections or vision problems could follow.
No illnesses have been reported so far related to this recall.
Anyone with the recalled nasal wash product should throw it away or return it for a full refund.
Most of the time staph is harmless, but it can sometimes cause infections. People with chronic illnesses are at higher risk of getting staph infections.
In healthcare settings, where people often pick up staph, it can lead to serious illness or death.
AD
Can Inexpensive ‘Struggle Meals’ Get a Healthier Makeover?
High grocery prices are stressing us out: An August poll found that 53 percent of Americans said grocery expenses were a “major source of stress,” and another 33 percent said they’re a “minor stress,”
ADHD Drugs Under Scrutiny by RFK Jr.'s Make America Healthy Again (MAHA) Commission
A recent White House executive order is focusing national attention on medications used to treat attention deficit hyperactivity disorder (ADHD) and raising concerns among mental health experts about
Eating More Fish May Slow MS Disability Progression
Fatty fish have previously been linked with lower levels of multiple sclerosis (MS) disability, and a recent study adds further support to the benefits of fish consumption when it comes to living with
FDA Approves New Treatment for People With Plaque Psoriasis
The U.S. Food and Drug Administration (FDA) approved Zoryve (roflumilast) cream 0.3 percent for the treatment of plaque psoriasis, including intertriginous areas (where skin rubs against other skin) iAD
FDA Approves New Vitiligo Treatment, Ruxolitinib (Opzelura)
On July 18, the U.S. Food and Drug Administration (FDA) approved ruxolitinib (Opzelura) cream 1.5 percent as a treatment for the most common form of vitiligo, according to a statement by Incyte, the m
Even a 3-Day Juice Cleanse Could Be Bad for Your Gut Health
People often turn to juice cleanses as a way to “detox” after weeks or months of unhealthy eating, or as a quick way to lose weight. But a small new study shows that consuming only liquids made from fAD
AD